Asperger Syndrome clinical trials
The registry lists 83 studies for Asperger Syndrome across more than 10 countries. 9 are recruiting or about to start. 14 of them are mainly about Asperger Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Asperger Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of South Florida (6) · Massachusetts General Hospital (4) · Yale University (4) · Boston Children's Hospital (3) · National Institute of Mental Health (NIMH) (3) · Forest Laboratories (3) · University of Pennsylvania (2) · New York State Psychiatric Institute (2)
What is being tested here
Drugs under test in Asperger Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Memantine | 0 | 0 | 4 |
| Aripiprazole | 0 | 0 | 3 |
| Guanfacine | 0 | 0 | 1 |
| Milnacipran | 0 | 0 | 1 |
| Oxytocin | 0 | 0 | 1 |
| Mirtazapine | 0 | 1 | 1 |
| Acetylcysteine | 0 | 0 | 1 |
| Lurasidone | 0 | 0 | 1 |
| Citalopram | 0 | 0 | 1 |
| Cycloserine | 0 | 1 | 1 |
Drug classes tested here Antipsychotics 5
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Dec 2026Mitochondrial Dysfunction in Autism Spectrum Disorder · University of Arkansas
- Apr 2027Recovery in Telling Life Stories · University of Aarhus
- May 2027Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders · Children's Hospital Medical Center, Cincinnati
Who these studies take
Of the 6 Asperger Syndrome studies recruiting now, 1 (17%) set no upper age limit and 5 (83%) stop at 75 or younger. 4 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (50%) | 3 (50%) |
| 18 | 5 (83%) | 5 (83%) |
| 30 | 3 (50%) | 3 (50%) |
| 40 | 2 (33%) | 2 (33%) |
| 50 | 1 (17%) | 1 (17%) |
| 65 | 1 (17%) | 1 (17%) |
| 75 | 1 (17%) | 1 (17%) |
| 85 | 1 (17%) | 1 (17%) |
Across all 83 studies, recruiting or not: 83% stop at 75 or younger and 83% at 65; 78% take children; 0% are for women only and 2% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 83. Browse all 83 → or search them.
- Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASDRecruitingNCT04532424Not applicable1 country
- QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable1 country
- Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental DisordersRecruitingNCT06227780Not applicable1 country
- Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum DisorderRecruitingNCT06859918Not applicable1 country
- Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment StudyEnrolling by invitationNCT03724136Not applicable2 countries
- The Supplementation Therapy in Autism and Response to Treatment StudyRecruitingNCT06187090Not applicable1 country
- Effects of a Multimodal Exercise Program for Children With ASDNot yet recruitingNCT05509231Not applicable
- ASDactive: An Integrated Theory-based Intervention to Promote Habitual Physical ActivityRecruitingNCT05958680Not applicable1 country
- SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of AutismRecruitingNCT032223752 countries
- Cognitive Neuroscience of Autism Spectrum DisordersCompletedNCT010314071 country
- Pediatric Patients With Metabolic or Other Genetic DisordersCompletedNCT027699491 country
- Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)CompletedNCT05176808Not applicable1 country
- Genetic Contributions to Autism Spectrum DisordersActive, not recruitingNCT011607831 country
- Behavior Therapy for Irritability in AutismCompletedNCT04654260Not applicable1 country
- Recovery in Telling Life StoriesActive, not recruitingNCT07082777Not applicable1 country
- Studies of Brain and Body InteractionCompletedNCT036722661 country
- Mitochondrial Dysfunction in Autism Spectrum DisorderActive, not recruitingNCT020002841 country
- Phenotypic and Genetic Factors in Autism Spectrum DisordersActive, not recruitingNCT009105591 country
- Sleep, Mood, and Quality of Life Issues in ASD Adolescents and Adults.Active, not recruitingNCT070330781 country
- Services to Enhance Social Functioning in Adults With Autism Spectrum DisordersCompletedNCT04788537Not applicable1 country
- Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderCompletedNCT03170453Not applicable1 country
- Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents with Autism Spectrum DisordersCompletedNCT013615031 country
- Methylphenidate ER Liquid Formulation in Adults With ASD and ADHDCompletedNCT02096952Phase 41 country
- Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum DisorderCompletedNCT01631851Not applicable1 country
- A Salivary miRNA Diagnostic Test for AutismCompletedNCT028325571 country
- Facilitating Employment for Youth With AutismCompletedNCT03560453Not applicable
- Understanding the Effects of Intervention on the Brain in AutismStatus unknownNCT02680015Not applicable1 country
- A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric DisordersCompletedNCT022503391 country
- Psychotherapy for Anxiety in Children With Autism Spectrum DisorderCompletedNCT02028247Not applicable1 country
- TMS for the Investigation of Brain Plasticity in Autism Spectrum DisordersCompletedNCT028364051 country
- Cognitive Behavioural Therapy (CBT) and Recreational Activity for Autism Spectrum Disorders (ASD)CompletedNCT01655173Not applicable1 country
- Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderCompletedNCT00902798Not applicable1 country
- Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental DisorderCompletedNCT01238575Phase 41 country
- Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult SampleCompletedNCT028006811 country
- Intranasal Oxytocin for the Treatment of Autism Spectrum DisordersCompletedNCT01337687Not applicable1 country
- Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of AutismCompletedNCT01337700Phase 41 country
- Predictors of Caregiver Adaptation to Pervasive Developmental DisordersCompletedNCT004962101 country
- GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education ProgramsCompletedNCT01808066Not applicable1 country
- Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid AnxietyCompletedNCT01919970Not applicable1 country
- Adolescent Social Skills Training ProgramCompletedNCT01031823Not applicable1 country
- Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With MemantineCompletedNCT01592747Phase 215 countries
- Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT01302964Phase 31 country
- Portable Visual Guidance System Phase IICompletedNCT00848874Not applicable1 country
- Cholesterol in ASD: Characterization and TreatmentCompletedNCT00965068Phase 1/21 country
- Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01565629Not applicable1 country
- A Folinic Acid Intervention for Autism Spectrum DisordersTerminatedNCT01602016Phase 21 country
- Memantine in Adult Autism Spectrum DisorderTerminatedNCT01078844Not applicable1 country
- A Study of Oral N-Acetylcysteine in Children With Autism Spectrum DisordersCompletedNCT00453180Phase 21 country
- Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 21 country
- Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in AutismTerminatedNCT01983189Phase 21 country